Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesThe Biotech Growth Trust PLC

The Biotech Growth Trust PLC

Financial Services Asset Management
PortfolioPortfolio WatchlistWatchlist
Company price
1372.0 GBX 36.00 ( 2.69%)
Last update at 2026-10-27T16:35:00Z
VOLUME
50408
Market Cap
257.09M

Momentum Score

…

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
1314.00
Low
1372.00
High
52 Week Price Range
658.00
Low
1320.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
1336.00
Dividend Yield
-
Revenue TTM
-15.17M
Revenue Per Share
-0.55
Gross Profit TTM
-15.17M
Debt / Equity
0.13
ROE
-6.98%
Net Debt
-8.45M
ROCE
-36.48%
Diluted EPS TTM
-0.14

Insight News

View All

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Income before tax -82.52M 74.76M -41.24M -202.27M 200.56M
Net income -82.66M 74.60M -41.30M -202.42M 200.43M
Selling general administrative 3.62M 3.17M 3.52M 3.22M 3.73M
Selling and marketing expenses 0.09M 0.07M 0.07M 0.07M 0.06M
Gross profit -78.81M 78.00M -37.65M -209.71M 222.11M
Ebit - 151.25M -42.03M -202.44M 200.38M
Ebitda -82.52M 74.76M -5.34M -2.69M 3.04M
Depreciation and amortization - -76.50M 36.69M 199.75M -197.34M
Operating income -82.52M 76.50M -36.69M -199.75M 197.34M
Other operating expenses 5.03M 3.85M 8.03M 2.85M 21.38M
Interest expense 1.32M 1.11M 0.79M 0.17M 0.18M
Tax provision 0.14M 0.16M 0.06M 0.15M 0.13M
Interest income 0.15M 0.12M 0.01M 0.00M 0.00M
Net interest income -1.18M -0.99M -0.78M -0.17M -0.18M
Income tax expense 0.14M 0.16M 0.06M 0.15M 0.13M
Total revenue -77.48M 80.35M -37.65M -209.71M 204.35M
Total operating expenses 3.71M 3.24M 3.59M -7.44M 3.80M
Cost of revenue 1.32M 2.35M - - -17.76M
Total other income expense net - -1.74M -4.55M -2.52M 3.21M
Net income from continuing ops -82.66M 74.60M -41.30M -202.42M 200.43M
Net income applicable to common shares - - -41.30M -202.42M 200.43M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 226.63M 411.42M 360.51M 427.45M 649.53M
Other current assets 0.02M 0.03M - - -
Total liab 5.42M 50.11M 30.22M 33.24M 48.06M
Total stockholder equity 221.21M 361.31M 330.29M 394.21M 601.47M
Other current liab - 5.28M 24.01M 32.79M 46.70M
Common stock 6.78M 8.37M 9.68M 10.29M 10.40M
Capital stock 6.78M 8.37M 9.68M 10.29M 10.40M
Retained earnings - -0.96M -51.65M -108.59M 78.26M
Other assets - 0.03M 427.45M 0.04M 0.04M
Cash 8.45M 2.13M 2.77M 1.50M 1.50M
Total current liabilities 0.41M 52.52M 30.22M 33.24M 48.06M
Current deferred revenue - -46.91M - - -
Net debt -8.45M 44.95M 17.40M 31.74M 25.28M
Short term debt - 47.08M - - -
Short long term debt total - 47.08M 20.17M 31.74M 26.78M
Other stockholder equity 214.43M 103.48M 41.97M 98.30M -88.66M
Total current assets 8.47M 16.67M 3.28M 0.05M 6.26M
Long term investments 218.16M 394.75M 357.23M 427.40M 643.27M
Net tangible assets - - 330.29M 394.21M 601.47M
Net receivables - 14.51M 0.49M 4.72M 4.72M
Inventory - 0.00M - - -
Accounts payable 0.41M 0.17M 6.21M 0.45M 1.37M
Accumulated other comprehensive income - 250.42M - - -
Common stock total equity - - - - 10.40M
Non currrent assets other 217.41M -394.75M -357.23M -427.40M -643.27M
Non current assets total 218.16M 394.75M 357.23M 427.40M 643.27M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Investments 115.85M 22.34M 45.69M 14.08M -26.16M
Change to liabilities - - -0.12M -18.25M 18.24M
Total cashflows from investing activities 115.85M 22.34M 45.69M 13.03M -25.55M
Net borrowings -48.48M 26.29M -15.33M 2.62M -2.56M
Total cash from financing activities -104.29M -18.74M -37.03M -2.39M 32.73M
Net income -82.52M 74.60M -41.24M -202.27M 200.56M
Change in cash 6.32M -0.64M 2.77M -1.50M 1.50M
Begin period cash flow 2.13M 2.77M 1.50M 1.50M 0.00M
End period cash flow 8.45M 2.13M 2.77M 1.50M 1.50M
Total cash from operating activities -5.09M -4.24M -5.89M -12.14M -5.67M
Issuance of capital stock - - 0.00M 2.10M 35.54M
Other cashflows from investing activities - - - -1.04M 0.61M
Dividends paid 0.00M 0.00M 0.00M 0.00M 0.00M
Change to account receivables 0.01M -0.01M 0.03M -0.01M 0.00M
Sale purchase of stock -54.48M -43.91M -20.91M -6.93M -106.08M
Other cashflows from financing activities -1.32M -1.11M -16.12M 2.44M -2.81M
Change to netincome - - 35.50M 208.55M -224.34M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital -0.34M 0.09M -0.09M -18.27M 18.24M
Other non cash items 77.77M -78.93M 35.44M 208.40M -224.47M
Free cash flow -5.09M -4.24M -5.89M -12.14M -5.67M

Peer Comparison*

Sector: Financial Services Industry: Asset Management

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
BIOG
The Biotech Growth Trust PLC		 36.00
2.69%		 1372.00 - - 4.90 1.00 4.96
MNTN
Schiehallion Fund Ltd		 -0.01
0.46%		 2.18 0.05 - 4.35 1.25 5.65
BHMU
BH Macro Limited		 -
-%		 4.29 0.09 - 39.01 0.71 6.47
TFG
Tetragon Financial Group Ltd		 0.15
1.00%		 15.10 0.02 7.04 1.16 0.31 2.06
BPCR
BioPharma Credit PLC		 0.00
0.41%		 0.98 0.09 - 6.73 0.91 7.95

Profile*

The Biotech Growth Trust PLC

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.

601 Lexington Avenue, New York, NY, United States, 10022

212-739-6400

https://www.biotechgt.com/index.php/biog/home/over

Name Title Year Born
Mr. Samuel David Isaly Portfolio Mang. 1945
Mr. Samuel David Isaly Portfolio Manager 1945

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…